Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript May 9, 2024
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Thank you for standing by. My name is Kath, and I will be your conference operator today. At this time, I would like to welcome...
